| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Oyster Point Pharma, Inc. | Chief Commercial Officer | Common Stock | 30,322 | $339,606 | $11.20 | 09 Jan 2022 | Direct |
| ALIMERA SCIENCES INC | Director | Common Stock | 0 | $0 | $3.83 | 16 Sep 2024 | Direct |
| Oyster Point Pharma, Inc. | Chief Commercial Officer | Employee Stock Option (Right to Buy) | 54,500 | 09 Jan 2022 | Direct | ||
| ALIMERA SCIENCES INC | Director | Stock Option (Right to Buy) | 0 | 16 Sep 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000110465924101114-snisarenko-john-2024-09-16 | ALIMERA SCIENCES INC | 16 Sep 2024 | 6 | $0 | 4 | Director | 18 Sep 2024, 21:53 |
| /report/000095017023051934-snisarenko-john-2023-10-02 | ALIMERA SCIENCES INC | 02 Oct 2023 | 1 | $0 | 4 | Director | 04 Oct 2023, 16:42 |
| /report/000147450623000011-snisarenko-john-2023-01-04 | ALIMERA SCIENCES INC | 04 Jan 2023 | 1 | $0 | 4 | Director | 06 Jan 2023, 16:19 |
| /report/000120919122002980-snisarenko-john-2022-01-09 | Oyster Point Pharma, Inc. | 09 Jan 2022 | 2 | $0 | 4 | Chief Commercial Officer | 11 Jan 2022, 18:47 |
| /report/000147450621000160-snisarenko-john-2021-11-02 | ALIMERA SCIENCES INC | 02 Nov 2021 | 1 | $0 | 4 | Director | 04 Nov 2021, 20:14 |
| /report/000120919121057629-snisarenko-john-2021-09-22 | Oyster Point Pharma, Inc. | 22 Sep 2021 | 1 | $0 | 4 | Chief Commercial Officer | 24 Sep 2021, 16:44 |